MedPath

Effects of Sugar Sweetened Beverage on Metabolic Health in Male and Female Adolescents

Not Applicable
Completed
Conditions
Insulin Tolerance
Insulin Sensitivity
Interventions
Dietary Supplement: high fructose sweetened beverage
Dietary Supplement: High Glucose sweetened beverage
Registration Number
NCT02058914
Lead Sponsor
University of Missouri-Columbia
Brief Summary

We examined the effects of short-term (2-wk) consumption of HF- and HG-sweetened beverages in adolescents (15-20 yr of age) on insulin sensitivity, insulin secretion, insulin clearance, triacylglycerol (TAG), and cholesterol concentrations.

Detailed Description

This counterbalanced study consisted of two trials including 1) high fructose (HF) trial and, 2) a high glucose (HG) trial. Each trial was blind to the participant, performed in a random order, and was 15 d in length. During days 1-14 of each trial, the participants consumed either 710 ml per day of a HF-sweetened beverage (sweetened with 50 g fructose and 15 g glucose) for 2-wk (HF trial) or 710 ml per day of a HG-sweetened beverage (sweetened with 50 g glucose and 15 g fructose) for 2-wk (HG trial) on top of their normal diet. In addition, the participants were instructed to maintain their normal physical activity levels during each trial (which were measured with an accelerometer). On day 15 of each trial, the participants reported to the lab after a \~ 11 h overnight fast for metabolic testing. During this testing day, the participants remained in the lab for 12 h and consumed three liquid meals (one meal every 4 h and HF meals during HF trial and HG meals during HG trial), while blood samples were taken every 15 or 30 min throughout the 12 h testing day. During testing, the participants remained physically inactive (\< 3,000 steps).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

males and females 15-20 years of age not participating in an organized sport (non-athletes) no history of heart, lung, kidney, endocrine, or gastrointestinal disease no medications known to alter glucose or lipid metabolism normal fasting blood glucose concentrations (< 100 mg/dL) normal fasting triglyceride concentrations (< 150 mg/dL) average daily fructose consumption < 90th percentile for age and sex

Exclusion Criteria

athlete type 1 diabetic type 2 diabetic consuming high quantities of fructose

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
high fructose sweetened beveragehigh fructose sweetened beverage710 ml per day of a HF-sweetened beverage (sweetened with 50 g fructose and 15 g glucose)
High Glucose sweetened beverageHigh Glucose sweetened beverageHG-sweetened beverage (sweetened with 50 g glucose and 15 g fructose)
Primary Outcome Measures
NameTimeMethod
glucose concentrationsbaseline and 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 255, 270, 285, 300, 315, 330, 360, 390, 420, 450, 480, 495, 510, 525, 540, 555, 570, 600, 630, 660, 690, and 720
Secondary Outcome Measures
NameTimeMethod
Triglyceridesbaseline and 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 255, 270, 285, 300, 315, 330, 360, 390, 420, 450, 480, 495, 510, 525, 540, 555, 570, 600, 630, 660, 690, and 720

Trial Locations

Locations (1)

University of Missouri

🇺🇸

Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath